Failure of second challenge with mogamulizumab in C-C chemokine receptor 4-positive cutaneous T-cell lymphoma

Romain Stammler; Van Anh Ta; Elisabeth Cohen; Caroline Ram-Wolff; Alizée Bozonnat; Gilles Battesti; Baptiste Louveau; Samia Mourah; Maxime Battistella; Hélène Moins-Teisserenc; Adèle de Masson

doi:10.1093/bjd/ljae085

Failure of second challenge with mogamulizumab in C-C chemokine receptor 4-positive cutaneous T-cell lymphoma

Br J Dermatol. 2024 May 17;190(6):920-921. doi: 10.1093/bjd/ljae085.

Authors

Romain Stammler^{1

2}, Van Anh Ta^{3

4}, Elisabeth Cohen³, Caroline Ram-Wolff¹, Alizée Bozonnat^{1

2

4}, Gilles Battesti^{1

2

4}, Baptiste Louveau^{2

4

5}, Samia Mourah^{2

4

5}, Maxime Battistella^{2

4

6}, Hélène Moins-Teisserenc^{3

4

7}, Adèle de Masson^{1

2

4}

Affiliations

¹ Department of Dermatology.
² INSERM U976.
³ INSERM U1160, Institut de Recherche Saint-Louis.
⁴ Université Paris Cité, Paris, France.
⁵ Department of Pharmacogenomics and Tumor Genomics.
⁶ Department of Pathology.
⁷ Haematology Laboratory, Saint Louis Hospital, AP-HP.

PMID: 38390970
DOI: 10.1093/bjd/ljae085

No abstract available

Publication types

Letter
Case Reports

MeSH terms

Aged
Antibodies, Monoclonal, Humanized* / adverse effects
Female
Humans
Lymphoma, T-Cell, Cutaneous* / drug therapy
Lymphoma, T-Cell, Cutaneous* / pathology
Male
Middle Aged
Receptors, CCR4* / antagonists & inhibitors
Receptors, CCR4* / metabolism
Skin Neoplasms* / drug therapy
Skin Neoplasms* / pathology
Treatment Failure

Substances

mogamulizumab
CCR4 protein, human